Logo image of RMT.MI

RIBA MUNDO TECNOLOGIA SL (RMT.MI) Stock Fundamental Analysis

BIT:RMT - Euronext Milan - ES0105724001 - Common Stock - Currency: EUR

3.1  +0.28 (+9.93%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to RMT. RMT was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of RMT have multiple concerns. While showing a medium growth rate, RMT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year RMT was profitable.
In the past year RMT has reported a negative cash flow from operations.
RMT.MI Yearly Net Income VS EBIT VS OCF VS FCFRMT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -10M -20M

1.2 Ratios

The last Return On Invested Capital (10.73%) for RMT is well below the 3 year average (19.20%), which needs to be investigated, but indicates that RMT had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.72%
ROE 5.09%
ROIC 10.73%
ROA(3y)5.18%
ROA(5y)N/A
ROE(3y)42.58%
ROE(5y)N/A
ROIC(3y)19.2%
ROIC(5y)N/A
RMT.MI Yearly ROA, ROE, ROICRMT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 20 40 60

1.3 Margins

RMT's Profit Margin has declined in the last couple of years.
RMT's Operating Margin has improved in the last couple of years.
RMT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.63%
PM (TTM) 0.16%
GM 4.77%
OM growth 3Y5.02%
OM growth 5YN/A
PM growth 3Y-46.15%
PM growth 5YN/A
GM growth 3Y5.47%
GM growth 5YN/A
RMT.MI Yearly Profit, Operating, Gross MarginsRMT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 1 2 3 4

More info and screens

2

2. Health

2.1 Basic Checks

RMT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, RMT has about the same amount of shares outstanding.
The debt/assets ratio for RMT is higher compared to a year ago.
RMT.MI Yearly Shares OutstandingRMT.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 500K 1M 1.5M 2M
RMT.MI Yearly Total Debt VS Total AssetsRMT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 5.20 indicates that RMT is not in any danger for bankruptcy at the moment.
RMT has a Debt/Equity ratio of 1.75. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.75
Debt/FCF N/A
Altman-Z 5.2
ROIC/WACC0.93
WACC11.5%
RMT.MI Yearly LT Debt VS Equity VS FCFRMT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

RMT has a Current Ratio of 1.54. This is a normal value and indicates that RMT is financially healthy and should not expect problems in meeting its short term obligations.
RMT has a Quick Ratio of 1.17. This is a normal value and indicates that RMT is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 1.17
RMT.MI Yearly Current Assets VS Current LiabilitesRMT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

RMT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -85.93%.
The Earnings Per Share has been growing slightly by 4.23% on average over the past years.
Looking at the last year, RMT shows a very strong growth in Revenue. The Revenue has grown by 31.93%.
Measured over the past years, RMT shows a very strong growth in Revenue. The Revenue has been growing by 93.55% on average per year.
EPS 1Y (TTM)-85.93%
EPS 3Y4.23%
EPS 5YN/A
EPS Q2Q%-75.08%
Revenue 1Y (TTM)31.93%
Revenue growth 3Y93.55%
Revenue growth 5YN/A
Sales Q2Q%25.35%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RMT.MI Yearly Revenue VS EstimatesRMT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.86 indicates a reasonable valuation of RMT.
Compared to an average S&P500 Price/Earnings ratio of 27.69, RMT is valued rather cheaply.
Industry RankSector Rank
PE 8.86
Fwd PE N/A
RMT.MI Price Earnings VS Forward Price EarningsRMT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.15
RMT.MI Per share dataRMT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RMT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RIBA MUNDO TECNOLOGIA SL

BIT:RMT (7/14/2025, 7:00:00 PM)

3.1

+0.28 (+9.93%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners5.53%
Inst Owner ChangeN/A
Ins Owners87.86%
Ins Owner ChangeN/A
Market Cap7.13M
Analysts80
Price Target10.2 (229.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-72.07%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.86
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B 0.52
P/tB 2.41
EV/EBITDA 1.15
EPS(TTM)0.35
EY11.29%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-5.58
FCFYN/A
OCF(TTM)-4.16
OCFYN/A
SpS188.76
BVpS6.01
TBVpS1.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.72%
ROE 5.09%
ROCE 16.67%
ROIC 10.73%
ROICexc 17.63%
ROICexgc 30.36%
OM 1.63%
PM (TTM) 0.16%
GM 4.77%
FCFM N/A
ROA(3y)5.18%
ROA(5y)N/A
ROE(3y)42.58%
ROE(5y)N/A
ROIC(3y)19.2%
ROIC(5y)N/A
ROICexc(3y)54.05%
ROICexc(5y)N/A
ROICexgc(3y)82.97%
ROICexgc(5y)N/A
ROCE(3y)29.82%
ROCE(5y)N/A
ROICexcg growth 3Y-8.88%
ROICexcg growth 5YN/A
ROICexc growth 3Y-13.63%
ROICexc growth 5YN/A
OM growth 3Y5.02%
OM growth 5YN/A
PM growth 3Y-46.15%
PM growth 5YN/A
GM growth 3Y5.47%
GM growth 5YN/A
F-Score4
Asset Turnover4.45
Health
Industry RankSector Rank
Debt/Equity 1.75
Debt/FCF N/A
Debt/EBITDA 2.81
Cap/Depr 216.57%
Cap/Sales 0.76%
Interest Coverage 0.95
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 1.17
Altman-Z 5.2
F-Score4
WACC11.5%
ROIC/WACC0.93
Cap/Depr(3y)822.65%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.77%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.93%
EPS 3Y4.23%
EPS 5YN/A
EPS Q2Q%-75.08%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)31.93%
Revenue growth 3Y93.55%
Revenue growth 5YN/A
Sales Q2Q%25.35%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.26%
EBIT growth 3Y103.27%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2033.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4214.12%
OCF growth 3YN/A
OCF growth 5YN/A